Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRNB2 | P17787 | 3/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | BAZ2A | Q9UIF9 | 5/20 | 0.40 |
| ▸ | AOC3 | Q16853 | 2/20 | 0.40 |
| ▸ | PRKCI | P41743 | 1/20 | 0.40 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | HTR2C | P28335 | 3/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.38 |
| ▸ | HTR3E | A5X5Y0 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | HTR3B | O95264 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3159092 | 1.00 | CHRNB2 (0.42) | CHRNB2CHRNA4RAB9ASMN1; SMN2BAZ2A | |
| SCHEMBL2623930 | 0.82 | RAB9A (0.56) | RAB9ASMN1; SMN2ARMAPK1MEN1 | |
| SCHEMBL30756603 | 0.82 | RAB9A (0.51) | RAB9ASMN1; SMN2ARMAPK1MEN1 | |
| Tert-Butyl Formate SCHEMBL27808996 | 0.82 | AOC3 (0.39) | CHRNB2CHRNA4RAB9ASMN1; SMN2BAZ2A | |
| SCHEMBL2624023 | 0.81 | RAB9A (0.58) | RAB9ASMN1; SMN2ARMAPK1MEN1 | |
| SCHEMBL28657476 | 0.79 | AR (0.54) | RAB9ASMN1; SMN2ARMAPK1MEN1 | |
| SCHEMBL12288858 | 0.79 | SMN1; SMN2 (0.41) | RAB9ASMN1; SMN2ARMAPK1MEN1 | |
| SCHEMBL27868573 | 0.79 | SMN1; SMN2 (0.41) | RAB9ASMN1; SMN2ARMAPK1MEN1 | |
| SCHEMBL2228747 | 0.78 | BAZ2A (0.49) | SMN1; SMN2BAZ2AAOC3MEN1LMNA | |
| SCHEMBL2698786 | 0.78 | NPC1 (0.60) | RAB9ASMN1; SMN2ARMAPK1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070112011-A1 | Substituted 1-propiolylpiperazine compounds, their preparation and use | GRUENENTHAL GMBH (DE) | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070112011-A1 | Substituted 1-propiolylpiperazine compounds, their preparation and use | GRM5, GRIK5, GRM1 | CHRNB2 175/4885CHRNA4 150/4885RAB9A 2783/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.